DrugDomain logoDrugDomain

Attributes

UniProt ID
Protein Name
DNA-directed DNA/RNA polymerase mu
Ligand Name
MAGNESIUM ION
DrugBank ID
None
PDB Ligand Accession
ChEMBL ID
n/a
PubChem ID
n/a
InChIKey
JLVVSXFLKOJNIY-UHFFFAOYSA-N
SMILES
[Mg+2]
Drug Action
No data available
Affinity Metrics
No affinity data available

3D Structure

Interactive Mol* view for the current protein-molecule pair.

Structure: 4M04
Hover over the Mol* viewer to rotate or zoom with the mouse. Move the cursor out of the viewer to go back to normal page scrolling and one-click navigation.
Hover inside the viewer to rotate or zoom. Move out to scroll the page or click links normally.
Color Legend
Unassigned regionsLigand / hetero atomse4m04A1e4m04A2e4m04A3
ECOD domains from experimental PDB structures interacting with ligand MG
UniProtDrugBankPDB LigandPDB IDECOD DomainRange Definition
Q9NP87n/aMG4m04e4m04A1A:289-364,A:384-494
Q9NP87n/aMG4m0ae4m0aA1A:289-364,A:385-494
Q9NP87n/aMG4ycxe4ycxA3A:289-494
Q9NP87n/aMG4yd1e4yd1A2A:289-494
Q9NP87n/aMG5twpe5twpA2A:289-364,A:385-494
Q9NP87n/aMG5twqe5twqA2A:289-364,A:385-494
Q9NP87n/aMG5twre5twrA1A:289-494
Q9NP87n/aMG5twse5twsA2A:289-364,A:385-494
Q9NP87n/aMG5txze5txzA3A:289-494
Q9NP87n/aMG5tybe5tybA3A:289-364,A:384-494
Q9NP87n/aMG5tyce5tycA3A:289-364,A:384-494
Q9NP87n/aMG5tyde5tydA1A:289-364,A:385-494
Q9NP87n/aMG5tyee5tyeA1A:289-364,A:384-494
Q9NP87n/aMG5tyfe5tyfA1A:289-364,A:384-494
Q9NP87n/aMG5tyge5tygA3A:289-494
Q9NP87n/aMG5vz7e5vz7A3A:289-494
Q9NP87n/aMG5vz8e5vz8A1A:289-494
Q9NP87n/aMG5vz9e5vz9A3A:289-365,A:385-494
Q9NP87n/aMG5vzae5vzaA2A:289-494
Q9NP87n/aMG5vzbe5vzbA3A:289-494
Q9NP87n/aMG5vzce5vzcA2A:289-365,A:385-494
Q9NP87n/aMG5vzde5vzdA2A:289-494
Q9NP87n/aMG5vzee5vzeA2A:289-494
Q9NP87n/aMG5vzfe5vzfA3A:289-365,A:385-494
Q9NP87n/aMG5vzge5vzgA1A:289-494
Q9NP87n/aMG5vzhe5vzhA1A:289-364,A:384-494
Q9NP87n/aMG5vzie5vziA2A:289-365,A:385-494
Q9NP87n/aMG6ipee6ipeA2A:289-365,A:385-494
Q9NP87n/aMG6ipge6ipgA2A:289-494
Q9NP87n/aMG6iple6iplA1A:289-494
Q9NP87n/aMG6ipme6ipmA3A:289-494
Q9NP87n/aMG6ipne6ipnA1A:289-494
Q9NP87n/aMG6p1ne6p1nA2A:289-494
Q9NP87n/aMG6p1oe6p1oA1A:289-364,A:384-494
Q9NP87n/aMG6p1pe6p1pA3A:289-494
Q9NP87n/aMG6p1qe6p1qA2A:289-364,A:384-494
Q9NP87n/aMG6p1re6p1rA2A:289-364,A:384-494
Q9NP87n/aMG6p1te6p1tA1A:289-494
Q9NP87n/aMG6p1ve6p1vA2A:289-364,A:384-494
Q9NP87n/aMG6p1we6p1wA1A:289-494
Q9NP87n/aMG6vf0e6vf0A1A:289-364,A:385-494
Q9NP87n/aMG6vf1e6vf1A1A:289-494
Q9NP87n/aMG6vf2e6vf2A1A:289-364,A:385-494
Q9NP87n/aMG6vf9e6vf9A1A:289-364,A:385-494
Q9NP87n/aMG6wice6wicA1A:289-494
Q9NP87n/aMG6wide6widA1A:289-494
Q9NP87n/aMG6wiee6wieA1A:289-365,A:385-494
Q9NP87n/aMG7co8e7co8A1A:289-494
Q9NP87n/aMG7co9e7co9A3A:289-494
Q9NP87n/aMG7cobe7cobA1A:289-494
Q9NP87n/aMG7coce7cocA3A:289-494
Q9NP87n/aMG7code7codA2A:229-288
Q9NP87n/aMG7code7codA3A:289-494
Q9NP87n/aMG7kswe7kswA1A:289-494
Q9NP87n/aMG7ksxe7ksxA1A:289-364,A:385-494
Q9NP87n/aMG7ksye7ksyA1A:289-364,A:384-494
Q9NP87n/aMG7kt0e7kt0A1A:289-494
Q9NP87n/aMG7kt7e7kt7A1A:289-494
Q9NP87n/aMG7kt8e7kt8A1A:289-364,A:384-494
Q9NP87n/aMG7kt9e7kt9A1A:289-364,A:385-494
Q9NP87n/aMG7ktee7kteA1A:289-494
Q9NP87n/aMG7ktfe7ktfA1A:289-364,A:384-494
Q9NP87n/aMG7ktge7ktgA1A:289-364,A:385-494
Q9NP87n/aMG7kthe7kthA1A:289-364,A:385-494
Q9NP87n/aMG7ktke7ktkA1A:289-494
Q9NP87n/aMG7ktne7ktnA1A:289-364,A:385-494